← Evidence map

ArticleActa diabetologica2023

Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.

Claudio Tiberti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects. | OpenQuestion